Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Tokyo Stock Exchange  >  Otsuka Holdings Co., Ltd.    4578   JP3188220002

OTSUKA HOLDINGS CO., LTD.

(4578)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsPress ReleasesOfficial PublicationsSector news
Latest news on OTSUKA HOLDINGS CO., LTD.
05/28OTSUKA : announces 1Q FY2020 financial results
PU
05/25OTSUKA HOLDINGS CO., LTD. : quaterly earnings release
04/21OTSUKA : Notice regarding Postponement of the Announcement of Consolidated Finan..
AQ
04/20OTSUKA : Notice regarding Postponement of the Announcement of Consolidated Finan..
PU
03/27OTSUKA : appoints Board Members and Audit & Supervisory Board Members (192KB)
PU
03/12OTSUKA : Chemical Announces Personnel Changes
AQ
03/11OTSUKA : Chemical Announces Personnel Changes (187KB)
PU
02/17OTSUKA : Announces Personnel Changes
AQ
02/14OTSUKA : announces FY2019 financial results
PU
02/14OTSUKA : Announces Personnel Changes (193KB)
PU
02/11OTSUKA HOLDINGS CO., LTD. : annual earnings release
2019OTSUKA HOLDINGS CO LTD : Ex-dividend day for final dividend
FA
2019FDA approves Intra-Cellullar's schizophrenia drug, shares soar 85%
RE
2019OTSUKA : Announcement of Changes in Company Officers at Otsuka Pharmaceutical Co..
AQ
2019OTSUKA : Announcement of Changes in Company Officers at Otsuka Pharmaceutical Co..
PU
2019Musashi Seimitsu to co-develop new engine with Israel's Aquarius
RE
2019LIVESTOCK HIGHLIGHTS : Top Stories of the Day
DJ
2019OTSUKA : Subsidiary Avanir Pharmaceuticals Reports Top-line Data from Second Pha..
PU
2019OTSUKA : Applies for the Additional Indication in Japan of Bipolar Disorder for ..
PU
2019OTSUKA : Adopts CO2-free Electricity Annual CO2 Emissions to Decline by Approxim..
AQ
2019OTSUKA : Adopts CO2-free Electricity Annual CO2 Emissions to Decline by Approxim..
PU
2019OTSUKA : announces 2Q FY2019 financial results
PU
2019OTSUKA : Notice concerning amendments to the forecasts for the first half of FY2..
AQ
2019OTSUKA : Notice concerning amendments to the forecasts for the first half of FY2..
PU
2019Hong Kong Politics Test Business -- WSJ
DJ
2019OTSUKA HOLDINGS CO LTD : Ex-dividend day for interim dividend
FA
2019OTSUKA : Electronics Announces Personnel Changes
AQ
2019OTSUKA : Electronics Announces Personnel Changes (96KB)
PU
2019OTSUKA : Taiho Oncology Announces Agreement with Otsuka to Commercialize Astex P..
AQ
2019OTSUKA : Otsuka announces the Third Medium-Term Management Plan
AQ
2019OTSUKA : announces the Third Medium-Term Management Plan (65KB)
PU
2019OTSUKA HOLDINGS CO LTD : quaterly earnings release
2019OTSUKA : Notice Regarding Company Split (Simplified Absorption–type Compan..
PU
2019OTSUKA : Notice Concerning Disposal of Treasury Shares as Restricted Stock Compe..
PU
2019OTSUKA : appoints Board Members and Audit & Supervisory Board Members (194KB)
PU
2019OTSUKA : Subsidiary Avanir Pharmaceuticals Reports Phase 3 Data Evaluating Inves..
PU
2019OTSUKA : and Lundbeck report phase III data evaluating brexpiprazole for the tre..
PU
2019Thailand to revoke foreign patent requests on marijuana
RE
2018OTSUKA HOLDINGS CO LTD : Ex-dividend day for final dividend
FA
2018ASIA MARKETS: Asian Markets Subdued But Higher Ahead Of U.S.-China Trade Talk..
DJ
2018OTSUKA : Notice Regarding Company Split (Simplified Absorption–type Compan..
PU
2018OTSUKA : Pharmaceutical Completes Acquisition of Visterra (84KB)
PU
2018OTSUKA : announces 2Q FY2018 financial results
PU
2018OTSUKA : Notice concerning amendments to the forecasts (IFRS) for the first half..
PU
2018OTSUKA : and Lundbeck's Rxulti® (brexpiprazole) approved by the European Commiss..
PU
2018OTSUKA : Pharmaceutical to Acquire Visterra (127KB)
PU
2018OTSUKA HOLDINGS CO LTD : Ex-dividend day for interim dividend
FA
2018OTSUKA : and Lundbeck's Rxulti® (brexpiprazole) receives positive opinion in EU ..
PU
2018OTSUKA : and Lundbeck to Start Third Phase 3 Trial in June to Evaluate Brexpipra..
PU
2018OTSUKA : and Lundbeck to Start Third Phase 3 Trial in June to Evaluate Brexpipra..
BU
2018OTSUKA : announces 1Q FY2018 financial results
PU
2018OTSUKA : JYNARQUE™ (tolvaptan) Approved by U.S. FDA as the First Treatment..
PU
2018OTSUKA : REXULTI® Tablets, a New Antipsychotic Drug, Launched in Japan (81KB)
PU
2018OTSUKA : Announces Personnel Changes (162KB)
PU
2018OTSUKA : announces FY2017 financial results.
PU
2018OTSUKA : Notice concerning amendments to financial forecasts for FY 2017 (87KB)
PU
2018OTSUKA : Signs Statement of Support for Women's Empowerment Principles (218KB)
PU
2018OTSUKA : Receives Approval in Japan for the Manufacture and Sale of New Antipsyc..
PU
2017OTSUKA HOLDINGS CO LTD : Ex-dividend day for final dividend
FA
2017OTSUKA : Notice Regarding Company Split (Simplified Absorption–type Compan..
PU
2017OTSUKA : announces 3Q FY2017 financial results
PU
2017OTSUKA : FDA Accepts Otsuka's Resubmission to Support a Regulatory Review of Tol..
BU
2017OTSUKA : U.S. FDA Accepts Otsuka's Resubmission to Support a Regulatory Review o..
PU
2017OTSUKA : Announces Phase 3 Results for Tolvaptan in Patients with Autosomal Domi..
PU
2017OTSUKA : Announces Phase 3 Results for Tolvaptan in Patients with Autosomal Domi..
BU
2017OTSUKA : Announces Phase 3 Results for Tolvaptan in Patients with Autosomal Domi..
BU
2017OTSUKA : Health Canada Approves Otsuka and Lundbeck's Abilify Maintena® (Aripipr..
BU
2017OTSUKA : and Lundbeck will Initiate a Third Phase 3 Trial to Evaluate Brexpipraz..
PU
2017OTSUKA : and Lundbeck Will Initiate a Third Phase 3 Trial to Evaluate Brexpipraz..
BU
2017OTSUKA : to Host Web Briefing on Tolvaptan Phase 3 Trial Results in Polycystic K..
BU
2017OTSUKA : and Lundbeck Announce Initiation of Two Phase 3 Trials of Brexpiprazole..
PU
2017OTSUKA : and Lundbeck Announce Initiation of Two Phase 3 Trials of Brexpiprazole..
BU
2017OTSUKA : Pharmaceutical Factory completes acquisition of additional equity in it..
PU
2017OTSUKA : Pharmaceutical Competes Acquisition of Daiya (88KB)
PU
2017OTSUKA : announces 2Q FY2017 financial results.
PU
1  2  3Next
Upcoming event on OTSUKA HOLDINGS CO., LTD.